Conditional recurrence analysis of intrahepatic cholangiocarcinoma: Changes in recurrence rate and survival after recurrence resection by disease‐free interval
Hepatology Research · 2023-12 · 53 (12) · 1224-1234
DOI: 10.1111/hepr.13951 ↗At a glance
Journal article in Hepatology Research, published online on 2023-08-21. Written by Harufumi Maki and 9 co-authors. Institution: Hepato-Biliary-Pancreatic Surgery Division, and Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, Th…. Cited 10 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Aim
The prognosis of patients with resected intrahepatic cholangiocarcinoma (ICC) is still unsatisfactory, with a high recurrence rate. We aimed to evaluate risks of recurrence changing over time and the survival benefit of resection for recurrent ICC.
Methods
This study included patients who underwent hepatectomy for ICC during 1995–2020. Risk factors for recurrence‐free survival (RFS) in patients undergoing initial resection and overall survival (OS) in patients who developed recurrence after initial resection were analyzed. Conditional cumulative incidence of recurrence was assessed.
Results
A total of 169 patients were included in the study and 114 patients (67.5%) developed recurrence. Cumulative analyses showed that the 5‐year recurrence rate was 69.3% at the time of initial resection but decreased to 24.8% in patients free from recurrence at 2 years after initial resection and 2.6% in patients free from recurrence at 4 years. Re‐resection was carried out in 26 (22.8%) of 114 patients who developed recurrence. Multivariable Cox proportional hazards model analysis indicated re‐resection (hazard ratio [HR] 0.19; 95% confidence interval [CI] 0.11–0.40, p < 0.001), microvascular invasion (MVI) (HR 2.39; 95% CI 1.05–5.40, p = 0.037), and disease‐free interval (months) (HR 0.97; 95% CI 0.95–1.00, p = 0.067) were significantly associated with longer OS after recurrence.
Conclusions
Although the rate of recurrence remains high, conditional cumulative recurrence rate analysis showed that the rate of recurrence decreased by disease‐free interval. Resection of recurrent ICC was associated with improved OS, particularly among patients with longer disease‐free interval and absence of MVI after initial hepatectomy.
Subjects
Author keywords
Authors and institutions
- Hepato-Biliary-Pancreatic Surgery Division, and Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID profiles: Yoshikuni Kawaguchi, Takeaki Ishizawa
Cite
APA
Maki, H., Kawaguchi, Y., Nagata, R., Mihara, Y., Ichida, A., Ishizawa, T., Akamatsu, N., Kaneko, J., Arita, J., & Hasegawa, K. (2023). Conditional recurrence analysis of intrahepatic cholangiocarcinoma: Changes in recurrence rate and survival after recurrence resection by disease‐free interval. Hepatology Research, 53(12), 1224-1234. https://doi.org/10.1111/hepr.13951
Vancouver
Maki H, Kawaguchi Y, Nagata R, Mihara Y, Ichida A, Ishizawa T, et al. Conditional recurrence analysis of intrahepatic cholangiocarcinoma: Changes in recurrence rate and survival after recurrence resection by disease‐free interval. Hepatology Research. 2023;53(12):1224-1234. doi:10.1111/hepr.13951
BibTeX
@article{Maki2023,
author = {Maki, Harufumi and Kawaguchi, Yoshikuni and Nagata, Rihito and Mihara, Yuichiro and Ichida, Akihiko and Ishizawa, Takeaki and Akamatsu, Nobuhisa and Kaneko, Junichi and Arita, Junichi and Hasegawa, Kiyoshi},
title = {Conditional recurrence analysis of intrahepatic cholangiocarcinoma: Changes in recurrence rate and survival after recurrence resection by disease‐free interval},
journal = {Hepatology Research},
year = {2023},
volume = {53},
number = {12},
pages = {1224--1234},
doi = {10.1111/hepr.13951}
}
EUVIMED